SIRT1 transgenic mice reduces the incidence of spontaneous carcinomas and the susceptibility to carcinogen-induced liver cancer [25] while SIRT1(+/−)/p53(+/−) mice have increased incidences of tumors in multiple tissues compared to SIRT1(+/+)/p53(+/−) mice. This evidence concerns the gene TP53 and liver cancer.